Arsena, H. and Munir, S.M. 2026. Efficacy and Safety of Adding Antiangiogenic Therapy to EGFR-Tyrosine Kinase Inhibitors versus EGFR-Tyrosine Kinase Inhibitor Monotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Bioscientia Medicina : Journal of Biomedicine and Translational Research. 10, 7 (Jun. 2026), 2624-2636. DOI:https://doi.org/10.37275/bsm.v10i7.1638.